Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Patients with Huntington disease (HD), a rare degenerative disorder of the central nervous system, have often been prescribed Reglan (metoclopramide) for the treatment of gastric problems even though the medication’s label says people with a history of depression, Parkinson’s disease or a movement disorder, and epilepsy or other seizure disorder should not take the drug.

Read the rest of this entry »

Warner Chilcott, the makers of Sarafem (fluoxetine hydrochloride), a treatment for Premenstrual Dysphoric Disorder (PMDD), have issued a warning about the risk of neuroleptic malignant syndrome, also known as Tardive Dyskinesia, a condition in which a person develops involuntary movements of his muscles similar to Parkinson’s Disease.

Read the rest of this entry »